Navigation Links
Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
Date:8/8/2008

share, compared with a net loss for the second quarter of 2007 of $4.8

million, or $0.07 per share. Net loss for the six months ended June

30, 2008 was $21.0 million, or $0.27 per share, compared with a net

loss of $8.2 million, or $0.11 per share, for the comparable period

last year.

-- Revenues for the second quarter of 2008 were $1.4 million, compared

with $709,000 for the second quarter of 2007. Revenues under

collaborative agreements for the second quarter of 2008 were $1.4

million, compared with $539,000 for the second quarter of 2007.

Revenues under collaborative agreements in 2008 primarily consisted of

the amortization of upfront fees received from Baxter and Roche of

$588,000 and research and development reimbursements from Baxter of

$554,000 and Roche of $210,000. Cumulase(R) product sales for the

second quarter of 2008 were $48,000, compared with $139,000 for the

second quarter of 2007.

-- Research and development expenses for the second quarter of 2008 were

$8.9 million, compared with $4.1 million for the second quarter of

2007, reflecting increased compensation expenses including share-based

compensation expenses, research and development spending on the

Company's Insulin, Bisphosphonates, and PEG PH20 clinical and

pre-clinical programs, and production costs associated with the

manufacturing scale-up of the Company's rHuPH20 enzyme.

-- Selling, general and administrative expenses for the second quarter of

2008 were $3.8 million, compared with $2.4 million for the second

quarter of 2007, reflecting increases in compensation expenses

including share-based compensation expenses, as well as higher legal

and facilities expenses compared with the prior-year quarter.

-- Cash and cash equivalents were $82.4 million as of Jun
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Halozyme Therapeutics to Present at the Jefferies 2nd Annual Healthcare Conference
2. Halozyme Therapeutics Reports 2008 First Quarter Financial Results
3. Halozyme Therapeutics to Hold Pipeline Update Conference Call on May 9
4. Halozyme Therapeutics Reports Fourth Quarter and Year End 2007 Financial Results
5. Halozyme Therapeutics Presents Favorable New Safety and Pharmacokinetic Data on rHuPH20 Enzyme Produced Via New Manufacturing Process at European Federation for Pharmaceutical Sciences
6. Halozyme Therapeutics to Hold Pipeline Update Conference Call on March 14
7. Halozyme Therapeutics to Present at the BIO CEO and Investor Conference and the Roth Growth Stock Conference
8. Halozyme Therapeutics Amends Stockholder Rights Plan
9. Halozyme Therapeutics Reports 2007 Third Quarter Financial Results
10. Halozyme Therapeutics to Present at UBS 2007 Global Life Sciences Conference
11. Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... January 22, 2015 Protocol Networks brings ... growing team of brand-neutral, independent consultants, Protocol Networks has ... explained that over the years, his company has attracted ... Town of Plainfield, as well as others. With the ...
(Date:1/22/2015)... 2015 Controlled Substance Compliance Services (CSCS), ... companies check the legal requirements around using controlled substances ... , As their international operations expand and become ... solutions built as a result of the first phase ...
(Date:1/22/2015)... PALO ALTO, Calif. , Jan. 22. 2015  Varian Medical ... equipment and software, has been honored for its commitment to ... most sustainable companies. Varian is the highest ranked healthcare equipment ... ranking, announced today during the World Economic Forum at ...
(Date:12/24/2014)... and NEW YORK , Dec. 24, ... company advancing patient care in critical areas, announced the closing ... stock, and warrants to purchase up to an aggregate 3,500,000 ... per share and $.01 per warrant.  The warrants have a ...
Breaking Biology Technology:Protocol Networks Brings Independent Technology Consulting to the Constitution State 2Global Compliance Service for Controlled Substances to Expand to China 2Varian Honored Among World's 100 Most Sustainable Corporations 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3
... Mass., Nov. 11 Contamination by an ... a cleanroom,s operation until,that organism can be ... effects on the schedules and productivity of ... new white paper, "The Microbial ID Breakthrough: ...
... Potential Benefits of Targeted Tissue Cooling During ... ... CXM ) and its operating unit InnerCool Therapies, Inc., today,announced ... is designed to induce localized cooling during surgery,for prostate cancer (radical ...
... Management to Host Teleconference on Monday, November 17, ... N.J., Nov. 11 Milestone,Scientific Inc. (OTC Bulletin ... today announced that the Company will,report its third ... nine,months ended September 30, 2008 on Friday, November ...
Cached Biology Technology:White Paper Details How DNA Sequencing Services Can Prevent Cleanroom Shutdowns at Medical Device and Pharmaceutical Manufacturers 2White Paper Details How DNA Sequencing Services Can Prevent Cleanroom Shutdowns at Medical Device and Pharmaceutical Manufacturers 3Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries 2Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries 3Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries 4Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries 5Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries 6Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries 7Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries 8Milestone to Report Results for 2008 Third Quarter on Friday, November 14, 2008 2Milestone to Report Results for 2008 Third Quarter on Friday, November 14, 2008 3
(Date:12/24/2014)... Dec. 23, 2014  Since its launch in December 2014, the ... the pain of trying to remember their usernames and passwords ... to their smartphones. To assist people who have struggled to ... that created 1U and focuses on redefining identity, announced today ...
(Date:12/19/2014)... Research and Markets ( http://www.researchandmarkets.com/research/8kmfcn/iphone_5s ) has ... Sensor - Apple/AuthenTec TMDR92 & Sapphire - Technology Report" ... http://photos.prnewswire.com/prnh/20130307/600769 Following the acquisition of ... feature with the iPhone 5S. It is currently the ...
(Date:12/17/2014)... 2014 Research and Markets ( http://www.researchandmarkets.com/research/s6qzt5/samsung_galaxy_s5 ) ... S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis" ... http://photos.prnewswire.com/prnh/20130307/600769 Based on a totally ... for the first time a fingerprint sensor in its ...
Breaking Biology News(10 mins):1U Offers Best Solution to the Username / Password Dilemma: For FREE! 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 3iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & Sapphire - Technology Report 2Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2
... the Mathematical Biosciences Institute (MBI) in the US have ... Biosciences Institute Graduate Lecture Series. The lecture series consists ... tutorial in nature and are inspired by annual programs ... The purpose of the MBI Graduate Lecture ...
... test developed at the Kansas State University Diagnostic Laboratory ... and potentially fatal -- virus that affects dogs, especially ... disease that involves both domestic and wild canines. It ... have not yet been vaccinated, said Richard Oberst, professor ...
... changes to Canada,s fisheries legislation "have eviscerated" the ... country,s fish species, scientists at the University of ... study. The changes were "politically motivated," unsupported ... and are inconsistent with ecosystem-based management, fisheries ...
Cached Biology News:New test can diagnose emerging strains of canine parvovirus 2New test can diagnose emerging strains of canine parvovirus 3Changes to fisheries legislation have removed habitat protection for most fish species in Canada 2
... Salmonella genomes has allowed the development of ... pairs. The S. enterica Typhimurium (strain LT2) ... bp; 4,440 ORFs) and a plasmid, pSLT ... Sigma-Genosys have been designed to amplify all ...
... own microplate stacker system, offers fast and ... host devices:, , Ultra Evolution , SAFIRE ... and SpectraFluor Plus , LS Series of ... supporting a wide range of detection and ...
... life easier. It offers a wide array of features ... *Instruments supported: ... XP, PR, SR, PG-S, PG, SG, AT, MT, UMT, ... User guidance on the balance display ...
... STag Purification Kits enable rapid analytical to ... proteins produced from appropriate vectors. Sufficient reagents ... 1 mg target protein under native or ... S-protein Agarose, which specifically retains STag fusion ...
Biology Products: